Subcutaneous immunoglobulin
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Subcutaneous immunoglobulin, covering 2008-02-21 to 2025-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Subcutaneous Immunoglobulin for Myasthenia Gravis [Phase 2]